IN2015DN00585A - - Google Patents

Download PDF

Info

Publication number
IN2015DN00585A
IN2015DN00585A IN585DEN2015A IN2015DN00585A IN 2015DN00585 A IN2015DN00585 A IN 2015DN00585A IN 585DEN2015 A IN585DEN2015 A IN 585DEN2015A IN 2015DN00585 A IN2015DN00585 A IN 2015DN00585A
Authority
IN
India
Prior art keywords
peptide
hexamer
cyclized
avoidance
natural
Prior art date
Application number
Other languages
English (en)
Inventor
Bernhard Fischer
Rudolf Lucas
Hendrik Fischer
Original Assignee
Apeptico Forschung & Entwicklung Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48672620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2015DN00585(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Apeptico Forschung & Entwicklung Gmbh filed Critical Apeptico Forschung & Entwicklung Gmbh
Publication of IN2015DN00585A publication Critical patent/IN2015DN00585A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IN585DEN2015 2012-06-28 2013-06-19 IN2015DN00585A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12173983.3A EP2679239A1 (fr) 2012-06-28 2012-06-28 Composition pharmaceutique pour le traitement de la forme pulmonaire du mal d'altitude provoqué par le manque d'oxygène et la pression atmosphérique réduite
PCT/EP2013/062777 WO2014001177A1 (fr) 2012-06-28 2013-06-19 Composition pharmaceutique pour traiter la forme pulmonaire du mal de l'altitude causée par la raréfaction de l'oxygène et la diminution de la pression atmosphérique

Publications (1)

Publication Number Publication Date
IN2015DN00585A true IN2015DN00585A (fr) 2015-06-26

Family

ID=48672620

Family Applications (1)

Application Number Title Priority Date Filing Date
IN585DEN2015 IN2015DN00585A (fr) 2012-06-28 2013-06-19

Country Status (14)

Country Link
US (2) US9802985B2 (fr)
EP (2) EP2679239A1 (fr)
JP (1) JP6113277B2 (fr)
KR (1) KR102010793B1 (fr)
CN (1) CN104427993B (fr)
AP (1) AP2014008162A0 (fr)
AU (1) AU2013283563B2 (fr)
CA (1) CA2875749C (fr)
EA (1) EA030384B1 (fr)
ES (1) ES2602197T3 (fr)
IN (1) IN2015DN00585A (fr)
MX (1) MX354302B (fr)
PE (1) PE20150198A1 (fr)
WO (1) WO2014001177A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6644695B2 (ja) * 2014-03-04 2020-02-12 アペプティコ フオルシユング ウント アントウィクラング ゲーエムベーハー 肺内炎症の減弱化
WO2015140125A2 (fr) * 2014-03-18 2015-09-24 Apeptico Forschung Und Entwicklung Gmbh Médicament peptidique sous forme de poudre sèche
US11111160B2 (en) 2015-08-25 2021-09-07 Bar-Ilan University Asymmetric electrochemical cell apparatus, and operating methods thereof
WO2018211474A1 (fr) 2017-05-19 2018-11-22 Trudell Medical International Dispositif à pression expiratoire positive
USD874064S1 (en) 2018-05-18 2020-01-28 Trudell Medical International Mask
USD903097S1 (en) 2018-05-18 2020-11-24 Trudell Medical International Mask
USD893806S1 (en) 2018-11-09 2020-08-18 Trudell Medical Internationl Mask and shroud
WO2021087037A1 (fr) * 2019-10-29 2021-05-06 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Peptide de ciblage spécifique du poumon (ltp), compositions et utilisations associées
EP4051307B1 (fr) 2020-05-08 2023-02-01 APEPTICO Forschung und Entwicklung GmbH Peptide pour la prévention ou le traitement du covid-19
KR20250164550A (ko) 2024-05-16 2025-11-25 장태현 고산병 예방을 위한 입술용 화장료 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
US5891679A (en) 1993-02-03 1999-04-06 N.V. Innogenetics S.A. TNF-alpha muteins and a process for preparing them
AU764992B2 (en) * 1998-08-14 2003-09-04 LUCAS, Rudolf Dr. TNF-derived peptides for use in treating oedema
CA2575513C (fr) 2004-08-06 2014-09-16 Altana Pharma Ag Composition comprenant un tensioactif pulmonaire et un peptide derive de tnf
EP2009023A1 (fr) 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Nouveaux peptides et leur utilisation pour le traitement de l'oedème
AT506150B1 (de) 2007-12-12 2010-01-15 Apeptico Forschung Und Entwick Zyklisches und cystein-freies peptid
MX2011009251A (es) * 2009-03-04 2011-11-18 Mannkind Corp Sistema mejorado de suministro de farmaco en polvo seco.
AT507953B1 (de) * 2009-03-05 2011-02-15 Apeptico Forschung & Entwicklung Gmbh Verfahren zur vermeidung und zur behandlung einer hyperpermeabilität
AT509267A1 (de) 2010-01-14 2011-07-15 Apeptico Forschung & Entwicklung Gmbh Organische verbindungen zur regulierung von vektoriellen ionenkanälen
AT510585B1 (de) * 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase

Also Published As

Publication number Publication date
AU2013283563B2 (en) 2017-06-08
CA2875749A1 (fr) 2014-01-03
US20190211061A1 (en) 2019-07-11
MX2014015048A (es) 2015-06-05
ES2602197T3 (es) 2017-02-20
EP2866824B1 (fr) 2016-08-10
US9802985B2 (en) 2017-10-31
MX354302B (es) 2018-02-23
AP2014008162A0 (en) 2014-12-31
EA030384B1 (ru) 2018-07-31
CN104427993B (zh) 2017-03-08
US20150225460A1 (en) 2015-08-13
KR20150037815A (ko) 2015-04-08
JP6113277B2 (ja) 2017-04-12
JP2015526399A (ja) 2015-09-10
CN104427993A (zh) 2015-03-18
PE20150198A1 (es) 2015-02-19
EP2866824A1 (fr) 2015-05-06
EP2679239A1 (fr) 2014-01-01
WO2014001177A1 (fr) 2014-01-03
KR102010793B1 (ko) 2019-08-14
EA201500061A1 (ru) 2015-06-30
AU2013283563A1 (en) 2015-01-15
CA2875749C (fr) 2019-02-26

Similar Documents

Publication Publication Date Title
IN2015DN00585A (fr)
HK1202800A1 (en) Therapeutic uses of fibroblast growth factor 21 proteins
MX2012009748A (es) USO DE PEPTIDOS INHIBIDORES DEL FACTOR DE CRECIMIENTO TRANSFORMANTE-BETA1(TGF-ß1) PARA EL TRATAMIENTO DE FIBROSIS Y/U OPACIDAD CORNEAL.
WO2015048348A3 (fr) Compositions et formulations pour augmenter la fonction rénale et traitement et prévention de maladies rénales, et procédés de production et d'utilisation de celles-ci
WO2014205317A3 (fr) Peptides cycliques utilisés en tant qu'agents de ciblage de protéines
MX356129B (es) Peptidos y analogos de peptidos protectores de los tejidos para evitar y tratar padecimientos y desordenes asociados con daño de los tejidos.
SG10201803862UA (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
UA118167C2 (uk) Пептид та його застосування
IL223867B (en) Recombinant human follicle stimulating hormone, compositions comprising the same and uses thereof
WO2015009820A3 (fr) Peptides et analogues peptidiques protecteurs tissulaires permettant de prévenir et traiter des maladies et des troubles associés à une lésion tissulaire
PH12015501870B1 (en) Nutritional compositions containing a peptide component with adiponectin stimulating properties and uses thereof
EP4653537A3 (fr) Rhodopsin-gentherapie zur regeneration des sehvermögens oder zur verhinderung der abnahme des sehvermögens
WO2013021284A3 (fr) Composition de vaccin anti-il-6
SG10201805646WA (en) Angiopoietin-like 4 antibodies and methods of use
WO2016020882A3 (fr) Anticorps de type angiopoétine 4 (angptl4) et procédés d'utilisation
WO2011123858A3 (fr) Peptides ccn3 à visée thérapeutique et leurs analogues
WO2012019086A3 (fr) Inhibition de la phosphatase lar pour amplifier l'angiogenèse thérapeutique
WO2009158238A3 (fr) Analogues de facteur de croissance de fibroblaste (fgf) et leurs utilisations
MY193996A (en) Tripeptide compound, preparation method therefor, and application thereof
EP4219534A3 (fr) Procédés de traitement et de prophylatise contre les troubles inflammatoires
PH12015502072B1 (en) Nutritional compositions containing a peptide component and uses thereof
EP4253405A3 (fr) Variante de protéine bpifb4
HUE061288T2 (hu) Aktív oxigén vegyületeket tartalmazó formulációk és berendezések azok alkalmazására
MX2017011654A (es) Analogos ciclicos de galanina y usos de los mismos.
WO2011119833A3 (fr) Peptides bmp-7 et procédés d'utilisation